BONEX.ST Stock — Price, Charts & Analysis

Bonesupport Holding AB (publ) (BONEX.ST) has a trailing P/E of 71.03x and a forward P/E of 52.17x. This places BONEX.ST in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

BONEX.ST trades with 71.03x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether BONEX.ST looks overvalued or undervalued.

BONEX.ST's P/E of 71.03x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

BONEX.ST's trailing EPS is SEK 3.21 and forward EPS is SEK 4.37. Reported earnings growth is 55.70%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Bonesupport Holding AB (publ) generated for each share. BONEX.ST's trailing EPS is SEK 3.21, and investors usually prefer EPS that is positive and growing over time.

Bonesupport Holding AB (publ) has a market cap of SEK 14.93B, making BONEX.ST a large-cap stock based on the current market value shown on Worldtickers.

BONEX.ST's latest stock price on Worldtickers is SEK 228.00. The latest move is SEK 1.80 or 0.80%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

BONEX.ST's quote includes a latest price of SEK 228.00. The market open is SEK 228.00. Previous close is SEK 226.20. The intraday range is SEK 225.00 to SEK 229.60.

BONEX.ST is up in the latest quote, with a move of SEK 1.80 or 0.80%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

BONEX.ST generated SEK 1.29B in trailing revenue. Revenue growth is 25.10%, which helps show whether demand is expanding or slowing.

BONEX.ST's revenue growth is 25.10%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, BONEX.ST shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SEK 213.91M.

Gross margin is 92.05%. Margins show how efficiently Bonesupport Holding AB (publ) turns revenue into profit.

Bonesupport Holding AB (publ) carries SEK 10.13M and holds SEK 434.31M in cash.

BONEX.ST holds SEK 434.31M on its balance sheet.

BONEX.ST's book value per share is SEK 14.42.

Institutions hold 65.24% of BONEX.ST shares. Insiders hold 10.47% of shares. Ownership mix helps investors understand how much of Bonesupport Holding AB (publ) is held by professional investors and company insiders.

BONEX.ST has 65.49M shares outstanding. Float shares are 58.89M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for BONEX.ST, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for BONEX.ST is SEK 4.37. Earnings growth is 55.70%. Revenue growth is 25.10%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

BONEX.ST's trailing EPS is SEK 3.21. Forward EPS is SEK 4.37. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

BONEX.ST is in the Healthcare sector. Its earnings multiple is 71.03x. Its latest displayed growth metric is 25.10%. Compare these figures with sector peers before deciding whether Bonesupport Holding AB (publ) is stronger or weaker than average.

BONEX.ST trades at SEK 228.00. The stock trades at 71.03x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Bonesupport Holding AB (publ)'s fundamentals.

BONEX.ST risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.49, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

BONEX.ST should be compared with companies in Medical Instruments & Supplies. Its earnings multiple is 71.03x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Bonesupport Holding AB (publ) (BONEX.ST) operates in Healthcare, specifically Medical Instruments & Supplies. Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V,

BONEX.ST trades on Stockholm. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

BONEX.ST stock is priced in SEK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Bonesupport Holding AB (publ)'s official website listed on Worldtickers is www.bonesupport.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Bonesupport Holding AB (publ) employs about 171 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Bonesupport Holding AB (publ) is headquartered in Lund, Sweden. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

BONEX.ST is in the Healthcare sector and the Medical Instruments & Supplies industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

BONEX.ST has traded between SEK 165.00 and SEK 323.00 over the past 52 weeks. At SEK 228.00, it is 29.41% below the high and 38.18% above the low. The 52-week range helps gauge long-term price momentum.

BONEX.ST is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is SEK 218.24 and its 200-day moving average is SEK 208.21.

BONEX.ST's RSI is 56.02. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

BONEX.ST's latest RSI reading is 56.02, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for BONEX.ST is near SEK 194.00. Key resistance is near SEK 236.20. Breaks above resistance or below support can change the short-term technical setup.

BONEX.ST's nearest reported support level is SEK 194.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

BONEX.ST's nearest reported resistance level is SEK 236.20. A breakout above resistance can improve momentum, especially when volume confirms the move.

BONEX.ST trades about 220.06K shares daily on average. The latest displayed volume is 96.49K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

BONEX.ST's MACD is 0.67, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

BONEX.ST is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 56.02 (neutral). MACD is bullish. Nearest support is around SEK 194.00. Resistance is around SEK 236.20. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SEK 219.32 (3.14% from price). MA50 is SEK 218.24 (3.65% from price). MA200 is SEK 208.21 (8.64% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. BONEX.ST's MA20 is SEK 219.32. MA50 is SEK 218.24. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

BONEX.ST's pivot is near SEK 224.87. Support is near SEK 194.00. Resistance is near SEK 236.20. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for BONEX.ST is near SEK 216.53. The next upper resistance zone is near SEK 244.80. These levels help define risk and possible follow-through zones after a breakout or breakdown.

BONEX.ST's Bollinger range is roughly SEK 203.62 to SEK 235.02. Band width is near 14.32%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

BONEX.ST's ATR-based typical daily range is about 3.90%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 96.49K shares. Average volume is about 220.06K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

BONEX.ST's all-time high shown on Worldtickers is SEK 405.80. Its all-time low is SEK 9.04. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

BONEX.ST has a beta of 0.49, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.